Corcept Therapeutics (CORT) 10-K2010 FY Annual report

Filed: 15 Mar 11, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: abuse, Affordability, Affordable, Agreementsfor, analyze, analyzing, asubstantivemilestone, attenuated, billion, biosource, bound, branded, brought, CI, concomitantly, Contemporary, Cushingoid, defamation, defraud, DRB, endocrinology, endometrial, escalation, experimental, fall, female, fraudulent, Genentech, guide, harassment, Head, HIPAA, hirsutism, hurdle, hypokalemia, induction, ingestion, inObesityin, instance, journalObesity, knowingly, licensure, Lo, mail, Medi, Merck, mITT, negligible, noncash, Octagon, opted, outweigh, passage, payor, pertain, pharmacy, Portability, PPACA, prednisone, Pty, Rebate, referral, reform, restructuring, scheme, seconday, sequence, slower, Southern, statute, stay, stayed, Steven, suggest, sunshine, thickening, title, transparency, Treasury, turner, turnover, UBC, unauthorized, uncancellable, unclear, underwritten, undiagnosed, Union, USPTO, valid, validation, Vermont, waiver, wereeither, willfully, worsened

Removed: acceleration, accredited, Additionally, advisor, affiliate, age, AI, aid, Allen, Alta, Amira, Amylin, Anderson, Andersson, Andrew, anniversary, Annuity, appointing, approach, approving, Arizona, Art, ascribed, assume, assumed, attained, attainment, attend, attended, attending, awarding, Bachelor, beneficially, BioPharma, Bird, CA, CAO, capacity, cardiovascular, CEO, CFO, Chair, chairmen, coinciding, combined, communicate, competitively, consideration, constitute, context, coordination, Coxe, creating, critical, culpable, custodian, deadline, decision, deductibility, deductible, defer, delegated, dental, descriptive, disability, disclaim, dispositive, earned, edward, eighteen, EITF, Embarcadero, ending, enhancing, environment, equally, evergreen, evidenced, exceeded, existed, expressing, factor, family, Farview, FASB, fixed, foregoing, forfeited, formula, formulaic, Foundation, founder, FTE, Gaither, goal, Gregory, Harvard, HBOC, hereinafter, Hill, iMcKesson, indemnified, indemnify, Ingenix, interested, interlocking, intricate, investor, involuntarily, involuntary, involvement, Jeffrey, job, judged, Julia, largest, leaving, LifeScan, light, link, linking, LLP, loan, lost, manager, marketable, matching, maximize, McKesson, McKinsey, measurable, Mercy, Mill, misconduct, Modern, motivate, Mountain, Museum, NCPB, NEO, Neurex, Nominating, nomination, Nomura, nugen, occupation, operator, opportunity, optical, orally, owner, Pamela, paper, Paperboy, paragraph, parent, participating, pecuniary, perspective, Phenomix, philosophy, pivotal, postpartum, practice, Princeton, privately, prohibited, proportionate, propose, QP, radio, receipt, recommended, recommending, recovered, reelected, referenced, reformulated, released, reliable, repaid, repeated, reserve, resignation, retention, retired, reviewing, Revocable, reward, Road, salary, satisfied, science, Scirex, seasoned, select, separate, SHAI, shared, shareholder, Sheehan, SHQP, spouse, standing, structured, substituted, successor, Suite, Sutter, Sweet, Symantec, talent, talented, television, Tench, Tennessee, Tercica, thereof, tie, travel, Trust, Trustee, UK, ultimate, understand, undertreated, unexercised, uniform, unit, Unrealized, Vanderbilt, vehicle, Wharton, White, William, Winnifred, worked, writing, Yale, Younger

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

CORT similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Corcept Therapeutics Incorporated

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Corcept Therapeutics Incorporated (the “Company”) on Form 10-K for the period ended December 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Joseph K. Belanoff, M.D., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ JOSEPH K. BELANOFF

Joseph K. Belanoff, M.D.

Chief Executive Officer

March 15, 2011